Suppr超能文献

COMPASS-ND神经退行性疾病研究中的衰弱患病率。

Frailty Prevalence in the COMPASS-ND Study of Neurodegenerative Disorders.

作者信息

Burt Jacqueline R, Godin Judith, Filion Josée, Montero-Odasso Manuel, Rockwood Kenneth, Andrew Melissa K, Camicioli Richard

机构信息

Division of Neurology, Department of Medicine, University of Alberta, Edmonton, AB, Canada.

Division of Geriatric Medicine, Department of Medicine, Dalhousie University, Halifax, NS, Canada.

出版信息

Can Geriatr J. 2019 Dec 30;22(4):205-212. doi: 10.5770/cgj.22.392. eCollection 2019 Dec.

Abstract

BACKGROUND

Frailty is characterized by increased vulnerability to adverse health outcomes. The prevalence of frailty across neurodegenerative disorders (NDD) is largely unknown. Symptoms of frailty and NDD overlap, calling into question a tautology in some frailty instruments. Our objectives were 1) to construct a Frailty Index (FI) independent of NDD symptoms, and 2) to estimate frailty prevalence in a broad NDD cohort using both the Frailty Phenotype (FP) and the constructed FI as measures.

METHODS

Data from the Canadian COMPASS-ND cohort study were assessed for applicability to FI construction. Frailty status according to FI and FP criteria were ascertained for each participant.

RESULTS

81 items were selected for the FI. In the cohort (150 participants; 46% women; mean age 73.6±7.0; 10 NDD subgroups), frailty was identified in 11% and 14% of participants according to the FI and FP, respectively. The difference between estimates was not significant. The FP classified most participants (84%) as pre-frail.

CONCLUSION

The presence of frailty elements, regardless of whether they are part of NDD, is likely to influence health status. Given the FP identified a large proportion of the cohort as pre-frail or frail, it is likely worthwhile to identify frailty in the context of NDD.

摘要

背景

衰弱的特征是对不良健康结局的易感性增加。神经退行性疾病(NDD)中衰弱的患病率很大程度上未知。衰弱和NDD的症状重叠,这使得一些衰弱评估工具中的同义反复受到质疑。我们的目标是:1)构建一个独立于NDD症状的衰弱指数(FI),以及2)使用衰弱表型(FP)和构建的FI作为测量方法,估计一个广泛的NDD队列中的衰弱患病率。

方法

评估来自加拿大COMPASS-ND队列研究的数据对构建FI的适用性。确定每位参与者根据FI和FP标准的衰弱状态。

结果

为FI选择了81个项目。在该队列(150名参与者;46%为女性;平均年龄73.6±7.0;10个NDD亚组)中,根据FI和FP分别确定11%和14%的参与者存在衰弱。估计值之间的差异不显著。FP将大多数参与者(84%)归类为衰弱前期。

结论

衰弱因素的存在,无论它们是否是NDD的一部分,都可能影响健康状况。鉴于FP将很大比例的队列参与者识别为衰弱前期或衰弱,在NDD背景下识别衰弱可能是值得的。

相似文献

1
Frailty Prevalence in the COMPASS-ND Study of Neurodegenerative Disorders.
Can Geriatr J. 2019 Dec 30;22(4):205-212. doi: 10.5770/cgj.22.392. eCollection 2019 Dec.
3
Longitudinal changes of frailty in 8 years: comparisons between physical frailty and frailty index.
BMC Geriatr. 2021 Dec 18;21(1):726. doi: 10.1186/s12877-021-02665-1.
5
Frailty phenotype, frailty index and risk of mortality in Chinese elderly population- Rugao longevity and ageing study.
Arch Gerontol Geriatr. 2019 Jan-Feb;80:115-119. doi: 10.1016/j.archger.2018.11.001. Epub 2018 Nov 6.
6
Comparison of Frailty Measures as Predictors of Outcomes After Orthopedic Surgery.
J Am Geriatr Soc. 2016 Dec;64(12):2464-2471. doi: 10.1111/jgs.14387. Epub 2016 Nov 1.
8
Cognitive Performance across 3 Frailty Phenotypes: Toledo Study for Healthy Aging.
J Am Med Dir Assoc. 2017 Sep 1;18(9):785-790. doi: 10.1016/j.jamda.2017.04.008. Epub 2017 Jun 13.
9
Frailty and Risk of Adverse Outcomes in Hospitalized Older Adults: A Comparison of Different Frailty Measures.
J Am Med Dir Assoc. 2017 Jul 1;18(7):638.e7-638.e11. doi: 10.1016/j.jamda.2017.04.011. Epub 2017 Jun 3.
10
High prevalence of frailty in end-stage renal disease.
Int Urol Nephrol. 2016 Aug;48(8):1357-1362. doi: 10.1007/s11255-016-1306-z. Epub 2016 May 10.

引用本文的文献

3
SIRT1 activation and its circadian clock control: a promising approach against (frailty in) neurodegenerative disorders.
Aging Clin Exp Res. 2022 Dec;34(12):2963-2976. doi: 10.1007/s40520-022-02257-y. Epub 2022 Oct 28.
4
Potentially inappropriate medication among people with dementia: towards individualized decision-making.
Eur Geriatr Med. 2021 Jun;12(3):569-575. doi: 10.1007/s41999-021-00502-7. Epub 2021 May 18.
5
Claims-Based Frailty and Outcomes: Applying an Aging Measure to Older Adults with Parkinson's Disease.
Mov Disord. 2021 Aug;36(8):1871-1878. doi: 10.1002/mds.28561. Epub 2021 Mar 23.
6
A Possible Association Between Executive Dysfunction and Frailty in Patients With Neurocognitive Disorders.
Front Psychol. 2020 Nov 11;11:554307. doi: 10.3389/fpsyg.2020.554307. eCollection 2020.
7
Multimorbidity and Frailty: Tackling Complexity in Parkinson's Disease.
J Parkinsons Dis. 2020;10(s1):S85-S91. doi: 10.3233/JPD-202105.

本文引用的文献

1
The Comprehensive Assessment of Neurodegeneration and Dementia: Canadian Cohort Study.
Can J Neurol Sci. 2019 Sep;46(5):499-511. doi: 10.1017/cjn.2019.27. Epub 2019 Jul 16.
3
Convergent validity of the electronic frailty index.
Age Ageing. 2019 Jan 1;48(1):152-156. doi: 10.1093/ageing/afy162.
4
Identification and management of frailty in the primary care setting.
CMAJ. 2018 Sep 24;190(38):E1134-E1140. doi: 10.1503/cmaj.171509.
5
Prevalence and Associated Factors of Sarcopenia and Frailty in Parkinson's Disease: A Cross-Sectional Study.
Gerontology. 2019;65(3):216-228. doi: 10.1159/000492572. Epub 2018 Sep 10.
6
Guidelines for Gait Assessments in the Canadian Consortium on Neurodegeneration in Aging (CCNA).
Can Geriatr J. 2018 Jun 30;21(2):157-165. doi: 10.5770/cgj.21.298. eCollection 2018 Jun.
7
Altered body composition, sarcopenia, frailty, and their clinico-biological correlates, in Parkinson's disease.
Parkinsonism Relat Disord. 2018 Nov;56:58-64. doi: 10.1016/j.parkreldis.2018.06.020. Epub 2018 Jun 13.
8
Motor and Cognitive Trajectories Before Dementia: Results from Gait and Brain Study.
J Am Geriatr Soc. 2018 Sep;66(9):1676-1683. doi: 10.1111/jgs.15341. Epub 2018 Apr 2.
9
Prevalence of Frailty in Mild to Moderate Alzheimer's Disease: A Systematic Review and Meta-analysis.
Curr Alzheimer Res. 2017;14(12):1256-1263. doi: 10.2174/1567205014666170417104236.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验